MedPath

Ancora Heart, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:2
Completed:6

Trial Phases

2 Phases

Phase 3:1
Not Applicable:9

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Not Applicable
9 (90.0%)
Phase 3
1 (10.0%)

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Not Applicable
Recruiting
Conditions
Heart Failure With Reduced Ejection Fraction (HFrEF)
Dilated Cardiomyopathy
Interventions
Device: AccuCinch Ventricular Restoration System
Drug: Guideline-Directed Medical Therapy
First Posted Date
2020-04-02
Last Posted Date
2025-06-08
Lead Sponsor
Ancora Heart, Inc.
Target Recruit Count
400
Registration Number
NCT04331769
Locations
🇺🇸

Grandview Medical Group Research, LLC, Birmingham, Alabama, United States

🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

and more 127 locations

Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation

Not Applicable
Completed
Conditions
Cardiomyopathy, Dilated
Heart Failure
First Posted Date
2018-06-18
Last Posted Date
2024-08-16
Lead Sponsor
Ancora Heart, Inc.
Target Recruit Count
5
Registration Number
NCT03560167
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

🇺🇸

Piedmont Heart, Atlanta, Georgia, United States

🇺🇸

Emory University, Atlanta, Georgia, United States

and more 16 locations

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

Not Applicable
Active, not recruiting
Conditions
Heart Failure
Cardiomyopathy, Dilated
First Posted Date
2018-05-23
Last Posted Date
2025-01-30
Lead Sponsor
Ancora Heart, Inc.
Target Recruit Count
22
Registration Number
NCT03533517
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

🇺🇸

Emory University Hospital Midtown, Atlanta, Georgia, United States

🇺🇸

University of Louisville, Louisville, Kentucky, United States

and more 15 locations

Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study

Not Applicable
Active, not recruiting
Conditions
Heart Failure
Cardiomyopathies
First Posted Date
2017-06-12
Last Posted Date
2025-01-29
Lead Sponsor
Ancora Heart, Inc.
Target Recruit Count
132
Registration Number
NCT03183895
Locations
🇧🇾

Republican Scientific and Practical Centre of Cardiology, Minsk, Belarus

🇧🇪

Onze Lieve Vrouwziekenhuis, Aalst, Aaslt, Belgium

🇧🇪

AZ Sint-Jan Brugge, Brugge, Belgium

and more 16 locations

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Not Applicable
Completed
Conditions
Heart Failure
Cardiomyopathies
Mitral Valve Insufficiency
First Posted Date
2016-06-20
Last Posted Date
2025-01-29
Lead Sponsor
Ancora Heart, Inc.
Target Recruit Count
35
Registration Number
NCT02806570
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

University of Louisville, Louisville, Kentucky, United States

🇺🇸

Minneapolis Heart Foundation Institute, Minneapolis, Minnesota, United States

and more 13 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath